WUXAY

WuXi AppTec Co., Ltd.

Healthcare · $75.3B market cap

Verdict

Share price

$27.10

close of Oct 3, 2026

Fair value

$11.19

Sticker Price

Payback Price

$4.48

buy price

Overpriced

WUXAY is Overpriced: at $27.10 it trades 142% above its fair value of $11.19. Its buy price (Payback Price) is $4.48, 83% below today's price. Business quality is strong: all 5 key numbers clear the 10% bar.

How we valued it

Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.

Business quality

5 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth23.9% a year✓
Equity per share growth18.8% a year✓
Sales growth26.7% a year✓
Free cash flow growth51.5% a year✓
Return on invested capital15.2%✓

Follow WUXAY

Get notified when it reaches its buy price of $4.48. Free.

Create a free account

About WuXi AppTec Co., Ltd.

WuXi AppTec Co., Ltd. functions as an investment holding entity, globally delivering a wide array of research, development, and manufacturing services. Operating across the People's Republic of China, other parts of Asia, the United States, and Europe, the company plays a crucial role in the discovery, advancement, and production of small molecule pharmaceuticals, as well as cell and gene therapies. The…

Medical - Diagnostics & Research

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works

WUXAY stock (WuXi AppTec Co., Ltd.): fair value $11.19, Overpriced — PaybackPrice